Ca.virogin.com is a subdomain of virogin.com, which was created on 2015-05-17,making it 9 years ago.
Description:Virogin Biotech Limited Leading oncolytic...
Discover ca.virogin.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 54.739 KB |
Page Load Time: 0.35333 Seconds |
Website IP Address: 192.64.119.34 |
IO Biotech, Inc. - Invest in combination cancer therapy investors.iobiotech.com |
American BioTech Supply – NSF/ANSI 456 Compliance nsf.americanbiotechsupply.com |
Biotech | Pall Corporation biopharmaceuticals.pall.com |
BIOTECH biotech.bio5.org |
Biotech and Pharmaceutical Industry Resources pharma.about.com |
BioTECH @ Richmond Heights 9-12 | The Only Conservation Biology Public Magnet High School biotech.dadeschools.net |
Biotech & Pharma | Informa Connect lifesciences.knect365.com |
Biotech Colleges in Maharashtra | RGITBT | Bharati Vidyapeeth rgitbt.bharatividyapeeth.edu |
AC2 Bio-Link | Promoting Biotech Education in Texas and Kentucky ac2.bio-link.org |
NCBiotech Company Directory | We make connections that create biotech jobs. directory.ncbiotech.org |
Science Careers Forum - Biotech, Pharmaceutical, Faculty, Postdoc jobs on Science Careers scforum.sciencecareers.org |
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace careers.biospace.com |
Products JH Biotech Inc dev.jhbiotech.com |
GC biotech webshop – GC biotech – Translating Life Sciences Into shop.gcbiotech.com |
date: Wed, 10 Jun 2020 13:51:41 GMT |
strict-transport-security: max-age=0 |
expires: Thu, 01 Jan 1970 00:00:00 GMT |
content-type: text/html;charset=utf-8 |
last-modified: Wed, 10 Jun 2020 13:51:41 GMT |
content-encoding: gzip |
etag: W/"fcfaa7b71ebe48b9dabff458ae83862c" |
content-length: 13198 |
Vary: Accept-Encoding |
Age: 915814 |
Accept-Ranges: bytes |
x-contextid: qRpGBoo1/rd53CEha |
server: Squarespace |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
charset="utf-8" |
content="Virogin Biotech" property="og:site_name" |
content="Virogin Biotech" property="og:title"/ |
content="https://virogin.com" property="og:url"/ |
content="website" property="og:type"/ |
content="Virogin Biotech Limited Leading oncolytic virotherapy" property="og:description"/ |
content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" property="og:image"/ |
content="1250" property="og:image:width"/ |
content="648" property="og:image:height"/ |
content="Virogin Biotech" itemprop="name"/ |
content="https://virogin.com" itemprop="url"/ |
content="Virogin Biotech Limited Leading oncolytic virotherapy" itemprop="description"/ |
content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" itemprop="thumbnailUrl"/ |
content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" itemprop="image"/ |
content="Virogin Biotech" name="twitter:title"/ |
content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" name="twitter:image"/ |
content="https://virogin.com" name="twitter:url"/ |
content="summary" name="twitter:card"/ |
content="Virogin Biotech Limited Leading oncolytic virotherapy" name="twitter:description"/ |
content="" name="description"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Background Leadership Team Scientific Advisory Board Technology Challenges Facing Oncolytic Virotherapy Synerlytic™ Platform Pipeline Business Development Partnering Investors News Contact UsBackground Leadership Team Scientific Advisory Board Technology Challenges Facing Oncolytic Virotherapy Synerlytic™ Platform Pipeline Business Development Partnering Investors News Contact Us Virotherapy to Ignite Immunotherapy VIROGIN AIMS TO BE A GLOBAL, BEST-IN-CLASS ONCOLYTIC VIRUS COMPANY THAT CREATES IMPACTFUL DRUGS FOR PATIENTS OF THE HIGHEST MEDICAL NEED. OUR MISSION IS TO DEVELOP NEXT GENERATION ONCOLYTIC VIROTHERAPIES TO ENHANCE THE SYSTEMIC ANTITUMOR IMMUNITY. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Learn About Our Technology Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market. Meet Our Leadership Team LATEST NEWS Featured Jan 22, 2020 Obtains Approval to Begin Phase I Clinical Trial in Australia Jan 22, 2020 Jan 22, 2020 Oct 23, 2019 Appoints New Advisors to Complement its Scientific Advisory Board Oct 23, 2019 Oct 23, 2019 May 8, 2019 to Form a Joint Venture with China’s Largest Pharmaceutical Company to Commercialize Oncolytic Virotherapies May 8, 2019 May 8, 2019 Read More3800 Wesbrook Mall, Vancouver, BC, V6S 2L9, Canada...
Domain Name: VIROGIN.COM Registry Domain ID: 1929677149_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2024-04-18T09:39:35Z Creation Date: 2015-05-17T04:00:54Z Registry Expiry Date: 2025-05-17T04:00:54Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:30:02Z <<<